Loading...
ARPA-H-SOL-26-147
Response Deadline
May 23, 2026, 3:59 AM(EDT)24 days
Eligibility
Contract Type
Solicitation
Amendment 3: Revised Appendix F: Administrative & National Policy Requirements Document, Section 3, Paragraph 1, to state that the Biographical Common Form, the Current and Pending (other) Support Common Form, and the Collaborators and Other Affiliations attachments may be provided during the negotiation phase after proposal selection.
Amendment 2: Added Appendices J & K under the Attachments section.
Amendment 1: Added Appendices A - I separately under the Attachments section.
The Advanced Research Projects Agency for Health (ARPA-H) is posting this Innovative Solutions Opening (ISO) in support of the One Comprehensive Universal Radiotherapy for Everyone (1-CURE) Program. ARPA-H anticipates that multiple Other Transaction (OT) Agreements will result from this announcement.
Interested parties are invited to review the attached 1-CURE_ISO_ARPA-H-SOL-26-147 and its Appendices A - C.
Additionally, proposers are encouraged to review the separate Special Notice, ARPA-H-SN-26-152, for information regarding the 1-CURE Proposers’ Day. Special Notice, ARPA-H-SN-26-152, is an independent announcement and is not attached to this ISO announcement.
All questions submitted to the ISO will be compiled and addressed. All answers will be posted to the 1-CURE Frequently Asked Questions (FAQ) page. Potential proposers are encouraged to monitor the FAQs page regularly for the latest information and updates: https://arpa-h.gov/explore-funding/programs/1-cure/faqs
The 1-CURE Team
DEPARTMENT OF HEALTH AND HUMAN SERVICES
NATIONAL INSTITUTES OF HEALTH
ADVANCED RESEARCH PROJECTS AGENCY FOR HEALTH (ARPA-H)
ADVANCED RESEARCH PROJECTS AGENCY FOR HEALTH (ARPA-H)
1301 K Street NW
Suite 1200 West
Washington, DC, 20005
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
PSC
HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT